Travere Therapeutics
TVTX
TVTX
261 hedge funds and large institutions have $3.01B invested in Travere Therapeutics in 2026 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 89 increasing their positions, 93 reducing their positions, and 58 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
14% less first-time investments, than exits
New positions opened: 50 | Existing positions closed: 58
23% less capital invested
Capital invested by funds: $3.9B → $3.01B (-$894M)
50% less funds holding in top 10
Funds holding in top 10: 8 → 4 (-4)
Holders
261
Holding in Top 10
4
Calls
$86.6M
Puts
$59.4M
Top Buyers
| 1 | +$40.4M | |
| 2 | +$33.9M | |
| 3 | +$33.9M | |
| 4 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
+$31.4M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$27.2M |
Top Sellers
| 1 | -$58.3M | |
| 2 | -$33.3M | |
| 3 | -$26.7M | |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
-$22.5M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$21.9M |
